Table of contents
Volume 91, Issue 10
Published online 9 November 2004 (1755-1852)
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Book Review |
Corrigendum
Clinical
The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease FREE
P A McArdle, D C McMillan, N Sattar, A M Wallace and M A Underwood
Br J Cancer 91: 1755-1757; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602211
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer FREE
J Feliu, J M Vicent, C García-Girón, M Constela, E Fonseca, J Aparicio, M Lomas, L Antón-Aparicio, F J Dorta, M González-Barón and and Oncopaz Cooperative Group and Associated Hospitals
Br J Cancer 91: 1758-1762; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602217
Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma FREE
J S Waters, C Moss, L Pyle, M James, S Hackett, R A'Hern, M Gore and T Eisen
Br J Cancer 91: 1763-1768; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602209
Phase II study of S-1 in patients with advanced biliary tract cancer FREE
H Ueno, T Okusaka, M Ikeda, Y Takezako and C Morizane
Br J Cancer 91: 1769-1774; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602208
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin FREE
Y Matsumura, T Hamaguchi, T Ura, K Muro, Y Yamada, Y Shimada, K Shirao, T Okusaka, H Ueno, M Ikeda and N Watanabe
Br J Cancer 91: 1775-1781; advance online publication, October 12, 2004; doi:10.1038/sj.bjc.6602204
The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group FREE
C Peters-Engl, P Konstantiniuk, C Tausch, A Haid, B Hoffmann, M Jagoutz-Herzlinger, F Kugler, S Redtenbacher, S Roka, P Schrenk and D Steinmassl
Br J Cancer 91: 1782-1786; advance online publication, October 12, 2004; doi:10.1038/sj.bjc.6602205
Psychosocial impact of breast/ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort FREE
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans and and Psychosocial Study Collaborators
Br J Cancer 91: 1787-1794; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602207
Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening FREE
L E M Duijm, J H Groenewoud, F H Jansen, J Fracheboud, M van Beek and H J de Koning
Br J Cancer 91: 1795-1799; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602158
Molecular and Cellular Pathology
A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin FREE
S A Glynn, P Gammell, M Heenan, R O'Connor, Y Liang, J Keenan and M Clynes
Br J Cancer 91: 1800-1807; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602221
Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells FREE
X Jin, D R Gossett, S Wang, D Yang, Y Cao, J Chen, R Guo, R K Reynolds and J Lin
Br J Cancer 91: 1808-1812; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602214
Real-time RT–PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer FREE
I H Benoy, H Elst, I Van der Auwera, S Van Laere, P van Dam, E Van Marck, S Scharpé, P B Vermeulen and L Y Dirix
Br J Cancer 91: 1813-1820; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602189
Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity FREE
F Rehman, P Shanmugasundaram and M P Schrey
Br J Cancer 91: 1821-1828; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602212
Genetics and Genomics
BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study FREE
T Bjørge, A K Lie, E Hovig, R E Gislefoss, S Hansen, E Jellum, H Langseth, K Nustad, C G Tropé and A Dørum
Br J Cancer 91: 1829-1834; advance online publication, October 12, 2004; doi:10.1038/sj.bjc.6602199
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma FREE
D Astuti, M Morris, C Krona, F Abel, D Gentle, T Martinsson, P Kogner, H P H Neumann, R Voutilainen, C Eng, P Rustin, F Latif and E R Maher
Br J Cancer 91: 1835-1841; advance online publication, October 26, 2004; doi:10.1038/sj.bjc.6602202
Experimental Therapeutics
Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis FREE
M Scaltriti, S Bettuzzi, R M Sharrard, A Caporali, A E Caccamo and N J Maitland
Br J Cancer 91: 1842-1850; advance online publication, October 19, 2004; doi:10.1038/sj.bjc.6602193
Book Review
Cancer and Its Management 4th Edition FREE
M J Lind
Br J Cancer 91: 1851; doi:10.1038/sj.bjc.6602210
Corrigendum
Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? FREE
R H Jack, M C Gulliford, J Ferguson and H Møller
Br J Cancer 91: 1852; doi:10.1038/sj.bjc.6602247
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
